Skip to content
Magazine
Wednesday, August 6, 2025
SUBSCRIBE
  • About Us
  • Belgium News
    • Belgium Police News
    • Brussels News
  • EU Institutions News
    • European Commission News
    • European Parliament News
    • European Council News
  • Europe News
  • World News
  • Belgium Business News
  • Culture and Society News
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Sustainable Perspective
    • Europe With Transparency
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
  • About Us
  • Belgium News
    • Belgium Police News
    • Brussels News
  • EU Institutions News
    • European Commission News
    • European Parliament News
    • European Council News
  • Europe News
  • World News
  • Belgium Business News
  • Culture and Society News
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Sustainable Perspective
    • Europe With Transparency
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
SUBSCRIBE

EU drugs regulator finds no evidence against AstraZeneca shot

Shiva Singh by Shiva Singh
1 April 2021
in Europe News
shutterstock_1918293236

A medical staff inoculates a woman with the AstraZeneca COVID-19 vaccine

Brussels (Brussels Morning) The European Medicines Agency (EMA) has said there is no scientific evidence to support restricting the use of the COVID-19 vaccine developed by British-Swedish AstraZeneca at this time, DW reported on Wednesday.

EMA Executive Director Emer Cooke pointed out that the agency will continue looking into reports of blood clots, but reiterated that EMA has not found a causal link between the vaccine and blood clots.

“According to the current scientific knowledge, there is no evidence that would support restricting the use of this vaccine in any population,” Cooke concluded.

Some have imposed restrictions 

Germany suspended the use of the AstraZeneca shot in March, only to lift the suspension for some age groups later on.

Several EU member states have temporarily halted the use of the shot for some age groups, citing the risk of blood clots.

According to EMA’s data, rare blood clots occurred in 4.8 cases per million AstraZeneca shots administered. This compared to 0.2 cases per million for Pfizer-BioNTech and zero for Moderna. In the case of the latter, EMA suggested this was likely because the Moderna vaccine is not widely used in Europe.

However, Thomas Mertens, chair of the German Standing Committee on Vaccination at the Robert Koch Institute, maintains that the age group restriction was necessary. “We have our own very solid data on this point,” he said, while noting that he was “not at all happy about this decision” even though, given the available data, it was necessary.

Mertens pointed out that doses would be reassigned from one group to another, saying he hoped the move would not significantly affect the country’s vaccination campaign.

Germany reported 31 blood clot cases in the week up to 29 March, representing a 100% increase compared to the period up to 22 March.

EMA noted it found 62 such cases worldwide in the period up to 22 March.

Related News:

  • UK regulator prepares for Astrazeneca vaccine
  • What Drugs Make Your Teeth Turn Black? Exploring The 5 Different Class of Drugs
  • EU preparing legal actions against AstraZeneca
  • German regulator halts Nord Stream 2 approval process
Tags: News
Next Post
paper ships with flags of Ukraine and Russia, symbol of conflict

US pledges support for Ukraine as ceasefire violations ramp up

Latest post

EU-elections-UK

EU elections: UK looks on from the “outside”

1 year ago
Galeries-Royales-Saint-Hubert

What Makes Galeries Royales Saint-Hubert an “Institution”?

1 year ago

Most Read

    Follow Brussels Morning
    Facebook Twitter Youtube Linkedin

    Browse Important News

    Belgium News
    Brussels News
    Culture and Society News
    Economy News
    EU Institutions News
    European Commission News
    European Council News
    European Parliament News
    Europe News
    Health And Fitness News
    Southeast Europe News
    Sustainable Perspective
    World News
    Diplomacy News
    US Elections News

    About Us

    Brussels Morning is a daily online newspaper based in Belgium. BM publishes unique and independent coverage on international and European affairs. With a Europe-wide perspective, BM covers policies and politics of the EU, significant Member State developments, and looks at the international agenda with a European perspective.

    More Info

    • About Us
    • Advertise With Us
    • Contact Us
    • Cookies Policy

    Join Our Newsletter

    Brussels Morning Newspaper – All Rights Reserved © 2024

    No Result
    View All Result
    • Home
    • About Us
    • Belgium News
      • Belgium Police News
      • Brussels News
    • Brussels Bubble
      • European Parliament News
      • European Commission News
      • European Council News
    • Wider Europe
      • Member States
    • World News
    • Business & Society
    • Europe With Transparency
    • Culture & Society
    • Policy Talks
      • Place de la Bourse
      • The Macro-Economist
      • Sustainable Perspective
      • Ambassador’s Corner
      • The American Angle
      • Southeast Europe
    • Print Magazine

    Brussels Morning Newspaper - All Rights Reserved © 2020

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
    Cookie settingsACCEPT
    Privacy & Cookies Policy

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
    Non-necessary
    Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
    SAVE & ACCEPT